Display options
Cite
Hull M, Klein M, Shafran S, et al. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. Can J Infect Dis Med Microbiol. 2013;24(4):217-38doi: 10.1155/2013/781410.
Hull, M., Klein, M., Shafran, S., Tseng, A., Giguère, P., Côté, P., Poliquin, M., & Cooper, C. (2013). CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 24(4), 217-38. https://doi.org/10.1155/2013/781410
Hull, Mark, et al. "CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 24,4 (2013): 217-38. doi: https://doi.org/10.1155/2013/781410
Hull M, Klein M, Shafran S, Tseng A, Giguère P, Côté P, Poliquin M, Cooper C. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. Can J Infect Dis Med Microbiol. 2013;24(4):217-38. doi: 10.1155/2013/781410. PMID: 24489565; PMCID: PMC3905006.
Copy Download .nbib Format: NLM
Share it on

Can J Infect Dis Med Microbiol. 2013;24(4):217-38. doi: 10.1155/2013/781410.

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Mark Hull, Marina Klein, Stephen Shafran, Alice Tseng, Pierre Giguère, Pierre Côté, Marc Poliquin, Curtis Cooper

Affiliations

  1. University of British Columbia, British Columbia Centre for Excellent in HIV/AIDS, Vancouver, British Columbia;
  2. McGill University, Montréal, Quebec;
  3. University of Alberta, Edmonton, Alberta;
  4. Toronto General Hospital, Toronto;
  5. The Ottawa Hospital Research Institute, Ottawa, Ontario;
  6. Clinique médicale du Quartier Latin, Montréal, Quebec;
  7. University of Ottawa, Ottawa, Ontario.

PMID: 24489565 PMCID: PMC3905006 DOI: 10.1155/2013/781410

Abstract

BACKGROUND: Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV, and is responsible for a heavy burden of morbidity and mortality. HIV-HCV management is more complex due to the accelerated progression of liver disease, the timing and nature of antiretroviral and HCV therapy, mental health and addictions management, socioeconomic obstacles and drug-drug interactions between new HCV direct-acting antiviral therapies and antiretroviral regimens.

OBJECTIVE: To develop national standards for the management of HCV-HIV coinfected adults in the Canadian context.

METHODS: A panel with specific clinical expertise in HIV-HCV co-infection was convened by The CIHR HIV Trials Network to review current literature, existing guidelines and protocols. Following broad solicitation for input, consensus recommendations were approved by the working group, and were characterized using a Class (benefit verses harm) and Level (strength of certainty) quality-of-evidence scale.

RESULTS: All HIV-HCV coinfected individuals should be assessed for HCV therapy. Individuals unable to initiate HCV therapy should initiate antiretroviral therapy to slow liver disease progression. Standard of care for genotype 1 is pegylated interferon and weight-based ribavirin dosing plus an HCV protease inhibitor; traditional dual therapy for 24 weeks (for genotype 2/3 with virological clearance at week 4); or 48 weeks (for genotypes 2-6). Therapy deferral for individuals with mild liver disease may be considered. HIV should not be considered a barrier to liver transplantation in coinfected patients.

DISCUSSION: Recommendations may not supersede individual clinical judgement.

Keywords: Antivirals; Direct-acting antivirals; HCV; HIV; Pharmacokinetics

References

  1. N Engl J Med. 2007 Jul 12;357(2):124-34 - PubMed
  2. Hepatology. 2012 May;55(5):1620-8 - PubMed
  3. Lancet. 2012 Jun 30;379(9835):2429-2438 - PubMed
  4. World J Gastroenterol. 2006 Jun 21;12(23):3756-9 - PubMed
  5. Am J Transplant. 2012 Jul;12(7):1866-76 - PubMed
  6. Hepatology. 2002 Jan;35(1):182-9 - PubMed
  7. N Engl J Med. 2005 Jun 23;352(25):2609-17 - PubMed
  8. Can J Public Health. 2005 Sep-Oct;96(5):344-7 - PubMed
  9. JAMA. 2000 Jan 5;283(1):74-80 - PubMed
  10. Lancet. 2010 Jan 30;375(9712):396-407 - PubMed
  11. Clin Infect Dis. 2009 Apr 1;48(7):963-72 - PubMed
  12. J Hepatol. 2007 Oct;47(4):527-37 - PubMed
  13. Can J Gastroenterol. 2012 Dec;26(12):917-38 - PubMed
  14. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e47-9 - PubMed
  15. HIV Med. 2006 May;7(4):248-54 - PubMed
  16. HIV Clin Trials. 2007 Jul-Aug;8(4):213-20 - PubMed
  17. AIDS. 2008 Oct 1;22(15):1979-91 - PubMed
  18. Hepatology. 2006 Nov;44(5):1139-45 - PubMed
  19. J Acquir Immune Defic Syndr. 2002 May 1;30(1):65-8 - PubMed
  20. Hepatology. 2011 Jul;54(1):20-7 - PubMed
  21. J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):320-3 - PubMed
  22. AIDS. 2009 Jul 31;23(12):F1-7 - PubMed
  23. Hepatology. 2005 Jan;41(1):48-54 - PubMed
  24. J Assoc Nurses AIDS Care. 2011 Jan-Feb;22(1):17-25 - PubMed
  25. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261-8 - PubMed
  26. Antivir Ther. 2010;15(1):91-9 - PubMed
  27. Ann Hepatol. 2012 Mar-Apr;11(2):179-85 - PubMed
  28. J Hepatol. 1997 Jan;26(1):1-5 - PubMed
  29. Lancet. 2003 Nov 22;362(9397):1708-13 - PubMed
  30. Curr Opin HIV AIDS. 2011 Nov;6(6):514-26 - PubMed
  31. Nature. 2009 Sep 17;461(7262):399-401 - PubMed
  32. N Engl J Med. 2011 Jun 23;364(25):2405-16 - PubMed
  33. J Hepatol. 2006;44(1 Suppl):S132-9 - PubMed
  34. AIDS. 2007 May 31;21(9):1073-89 - PubMed
  35. Eur J Clin Pharmacol. 2015 Mar;71(3):303-11 - PubMed
  36. Lancet Infect Dis. 2004 May;4(5):301-6 - PubMed
  37. Clin Infect Dis. 2012 Jul;55(2):279-90 - PubMed
  38. Am J Gastroenterol. 2001 Jan;96(1):179-83 - PubMed
  39. AIDS Res Treat. 2012;2012:197501 - PubMed
  40. HIV Clin Trials. 2008 Jan-Feb;9(1):43-51 - PubMed
  41. Am J Public Health. 2008 Mar;98(3):515-9 - PubMed
  42. Liver Int. 2010 Aug;30(7):1043-8 - PubMed
  43. Am J Gastroenterol. 2002 Oct;97(10):2614-8 - PubMed
  44. CMAJ. 2007 Jul 31;177(3):257-61 - PubMed
  45. Subst Abus. 2001 Dec;22(4):209-216 - PubMed
  46. Arch Intern Med. 2004 Nov 22;164(21):2349-54 - PubMed
  47. J HIV Ther. 2007 Mar;12(1):24-35 - PubMed
  48. AIDS. 2012 Sep 10;26(14):1845-6 - PubMed
  49. J Hepatol. 2009 Apr;50(4):736-45 - PubMed
  50. J Infect Dis. 2008 Nov 1;198(9):1337-44 - PubMed
  51. Antimicrob Agents Chemother. 2010 Apr;54(4):1647-9 - PubMed
  52. J Antimicrob Chemother. 2012 Aug;67(8):2020-8 - PubMed
  53. Ann Intern Med. 2012 Feb 21;156(4):271-8 - PubMed
  54. J Infect Dis. 2007 Sep 1;196(5):670-6 - PubMed
  55. Arch Intern Med. 2006 Aug 14-28;166(15):1632-41 - PubMed
  56. N Engl J Med. 2001 Nov 15;345(20):1452-7 - PubMed
  57. Infection. 2008 Jun;36(3):250-5 - PubMed
  58. Gastroenterology. 2008 Apr;134(4):960-74 - PubMed
  59. AIDS. 2004 Mar 26;18(5):767-74 - PubMed
  60. J Clin Microbiol. 2009 Dec;47(12):3832-8 - PubMed
  61. Transplantation. 2007 Sep 15;84(5):563-71 - PubMed
  62. Lancet. 2012 Jun 30;379(9835):2439-2448 - PubMed
  63. J Hepatol. 2006 Jan;44(1):47-55 - PubMed
  64. Can J Gastroenterol. 2012 Jun;26(6):359-75 - PubMed
  65. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4 - PubMed
  66. J Infect Dis. 2008 Apr 15;197(8):1213-4, author reply 1214-5 - PubMed
  67. Hepatology. 2000 Mar;31(3):777-82 - PubMed
  68. JAMA. 2004 Dec 15;292(23):2839-48 - PubMed
  69. Clin Infect Dis. 2007 Oct 15;45(8):969-74 - PubMed
  70. N Engl J Med. 2011 Jun 23;364(25):2417-28 - PubMed
  71. J Antimicrob Chemother. 2010 Nov;65(11):2450-4 - PubMed
  72. J Antimicrob Chemother. 2010 Jan;65(1):4-9 - PubMed
  73. J Viral Hepat. 2009 May;16(5):352-8 - PubMed
  74. J Hepatol. 2011 Jun;54(6):1137-44 - PubMed
  75. Hepatology. 2011 Oct;54(4):1433-44 - PubMed
  76. Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):949-53 - PubMed
  77. Curr Opin Organ Transplant. 2012 Jun;17(3):216-24 - PubMed
  78. HIV Med. 2012 Feb;13(2):127-31 - PubMed
  79. Hepatology. 2009 Aug;50(2):407-13 - PubMed
  80. Hepatology. 2013 Mar;57(3):974-84 - PubMed
  81. N Engl J Med. 2004 Jul 29;351(5):438-50 - PubMed
  82. N Engl J Med. 2011 Mar 31;364(13):1195-206 - PubMed
  83. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):564-70 - PubMed
  84. JAMA. 2012 Jul 25;308(4):387-402 - PubMed
  85. Ann Intern Med. 2004 Mar 2;140(5):346-55 - PubMed
  86. J Antimicrob Chemother. 2011 Dec;66(12):2843-9 - PubMed
  87. Hepatology. 2013 Mar;57(3):881-9 - PubMed
  88. BMJ. 2006 Jan 28;332(7535):220-2 - PubMed
  89. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):41-8 - PubMed
  90. Clin Infect Dis. 2005 Feb 15;40(4):588-93 - PubMed
  91. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):180-5 - PubMed
  92. Clin Infect Dis. 2013 Jan;56(1):143-50 - PubMed
  93. Ann Intern Med. 2000 Nov 7;133(9):665-75 - PubMed
  94. Antivir Ther. 2010;15(3):413-23 - PubMed
  95. Expert Rev Med Devices. 2010 Nov;7(6):811-23 - PubMed
  96. J Hepatol. 2011 Jan;54(1):41-7 - PubMed
  97. Hepatology. 2002 Sep;36(3):737-42 - PubMed
  98. World J Gastrointest Surg. 2011 Feb 27;3(2):21-8 - PubMed
  99. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8 - PubMed
  100. Sex Transm Infect. 2010 Feb;86(1):25-8 - PubMed
  101. Annu Rev Med. 2008;59:473-85 - PubMed
  102. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):175-9 - PubMed
  103. Curr Pharm Des. 2008;14(17):1690-7 - PubMed
  104. Clin Infect Dis. 2001 Aug 15;33(4):562-9 - PubMed
  105. Clin Infect Dis. 2012 Jun;54(12):1798-805 - PubMed
  106. Nature. 2009 Oct 8;461(7265):798-801 - PubMed
  107. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):63-7 - PubMed
  108. J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):551-6 - PubMed
  109. Antivir Ther. 2008;13(7):953-7 - PubMed
  110. Hepatology. 2011 Jul;54(1):3-5 - PubMed
  111. Hepatology. 2010 Oct;52(4):1225-31 - PubMed
  112. J Viral Hepat. 2010 Apr;17(4):280-6 - PubMed
  113. Int J Epidemiol. 2010 Oct;39(5):1162-9 - PubMed
  114. Drug Alcohol Rev. 2008 Nov;27(6):693-9 - PubMed
  115. Hepatology. 2004 May;39(5):1213-9 - PubMed
  116. J Viral Hepat. 2011 May;18(5):316-24 - PubMed
  117. Hepatology. 1994 Nov;20(5):1152-5 - PubMed
  118. J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):426-31 - PubMed
  119. Clin Infect Dis. 2006 Jun 15;42(12):1674-8 - PubMed
  120. BMC Public Health. 2010 Apr 29;10:225 - PubMed
  121. AIDS. 2012 Jan 28;26(3):335-43 - PubMed
  122. J Clin Microbiol. 1994 Aug;32(8):2031-4 - PubMed
  123. Clin Infect Dis. 2011 Mar 15;52(6):803-11 - PubMed
  124. BMC Public Health. 2012 Aug 09;12:632 - PubMed
  125. J Viral Hepat. 2003 Mar;10(2):118-25 - PubMed
  126. Blood. 1999 Aug 15;94(4):1183-91 - PubMed
  127. Sex Transm Infect. 2012 Nov;88(7):558-64 - PubMed
  128. AIDS. 2011 Jun 1;25(9):1229-32 - PubMed
  129. Curr Opin HIV AIDS. 2011 Jul;6(4):278-84 - PubMed
  130. Clin Infect Dis. 2012 Jun;54(12):1806-13 - PubMed
  131. J Clin Gastroenterol. 2010 Mar;44(3):214-9 - PubMed
  132. AIDS. 2000 Dec 22;14(18):2895-902 - PubMed
  133. BMC Gastroenterol. 2007 Oct 15;7:40 - PubMed
  134. N Engl J Med. 2011 Mar 31;364(13):1207-17 - PubMed
  135. Lancet Infect Dis. 2005 Sep;5(9):558-67 - PubMed
  136. HIV Med. 2012 Sep;13 Suppl 2:1-85 - PubMed
  137. AIDS. 2004 Oct 21;18(15):2039-45 - PubMed
  138. Can J Public Health. 2009 Jan-Feb;100(1):29-31 - PubMed
  139. J Infect Dis. 2002 Jul 1;186(1):23-31 - PubMed
  140. Hepatology. 2007 Oct;46(4):971-81 - PubMed
  141. AIDS. 2007 Mar 30;21(6):685-92 - PubMed
  142. J Infect. 2006 Jul;53(1):36-42 - PubMed
  143. Antivir Ther. 2008;13(3):429-37 - PubMed
  144. Ann Intern Med. 2003 Sep 16;139(6):493-8 - PubMed
  145. HIV Med. 2005 Nov;6(6):375-8 - PubMed
  146. AIDS. 2011 Feb 20;25(4):399-409 - PubMed
  147. AIDS. 2003 May 2;17(7):1023-8 - PubMed
  148. J Infect Dis. 2008 Sep 1;198(5):683-6 - PubMed
  149. Int J Drug Policy. 2011 Jan;22(1):70-6 - PubMed
  150. Clin Infect Dis. 2009 Mar 1;48(5):650-8 - PubMed
  151. J Antimicrob Chemother. 2008 Dec;62(6):1365-73 - PubMed
  152. Am J Gastroenterol. 2005 Jan;100(1):56-63 - PubMed
  153. Am J Gastroenterol. 1995 Sep;90(9):1543 - PubMed
  154. AIDS Res Hum Retroviruses. 2007 Aug;23(8):972-82 - PubMed
  155. CMAJ. 1999 Mar 9;160(5):659-65 - PubMed
  156. HIV Med. 2009 May;10(5):282-9 - PubMed
  157. Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):353-62 - PubMed
  158. J Hepatol. 2004 Jun;40(6):993-9 - PubMed
  159. Semin Liver Dis. 2005 Feb;25(1):52-64 - PubMed
  160. PLoS One. 2009;4(2):e4517 - PubMed
  161. J Infect Dis. 2007 Jul 15;196(2):230-8 - PubMed
  162. HIV Med. 2013 Jan;14(1):10-20 - PubMed
  163. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):463-9 - PubMed
  164. AIDS. 2011 Mar 27;25(6):777-86 - PubMed
  165. Hepatology. 2006 Jun;43(6):1317-25 - PubMed
  166. Curr Infect Dis Rep. 2012 Feb;14(1):67-82 - PubMed
  167. HIV Med. 2008 Feb;9(2):82-8 - PubMed
  168. HIV Med. 2005 Jul;6 Suppl 2:149-53 - PubMed

Publication Types